The settlement between Statera Biopharma, Inc. and Biostax Corp. includes an amended royalty-bearing license agreement and a joint petition to dismiss the involuntary bankruptcy case against ...

Under the terms of the settlement, insurance carriers would pay the $123 million in cash, minus any fees awarded to plaintiffs’ counsel and litigation expenses, to an escrow account.